SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001804220-24-000026
Filing Date
2024-08-01
Accepted
2024-08-01 07:06:07
Documents
15
Period of Report
2024-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K regn-20240801.htm   iXBRL 8-K 23730
2 EXHIBIT 99.1 exhibit991q22024.htm EX-99.1 458975
6 image0a12.jpg GRAPHIC 7835
  Complete submission text file 0001804220-24-000026.txt   650246

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT regn-20240801.xsd EX-101.SCH 1907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT regn-20240801_lab.xml EX-101.LAB 21615
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT regn-20240801_pre.xml EX-101.PRE 12512
17 EXTRACTED XBRL INSTANCE DOCUMENT regn-20240801_htm.xml XML 2835
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 241164188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)